Bolt Biotherapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Redwood City, CA
BOLT chart
What traders are saying about $BOLT
Latest postsBolt Biotherapeutics, Inc. news
- Sidley Represents Bolt Biotherapeutics in the Acquisition of Prana Therapies and Concurrent US$120 Million Private Placement Financing
Legal Desire ·
- $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Bolt Biotherapeutics, Inc. (NASDAQ: BOLT)
PR Newswire ·
- Bolt Biotherapeutics acquires Prana Therapies in US$120m deal
Health Tech World ·
- BOLT Soars As Bolt Biotherapeutics Lands Prana Reverse Merger Deal
Timothy Sykes ·
- Bolt Biotherapeutics Acquires Prana Therapies And Raises $120 Million To Advance PRA-216
Pulse 2.0 ·
- Bolt Biotherapeutics acquires Prana Therapies
The Pharmaletter ·
- Bolt Biotherapeutics, Inc. Estimates – NASDAQ:BOLT
TradingView ·
- Wilson Sonsini Advises Prana Therapies on IP Matters Related to Acquisition by Bolt Biotherapeutics
Wilson Sonsini ·
- Bolt Biotherapeutics acquires Prana Therapies, raises $120M
StreetInsider ·
- Why Is Penny Stock Bolt Biotherapeutics (BOLT) Up 62% Today?
TipRanks ·
- 12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga ·
- Biotech Stock Bolt Biotherapeutics (Nasdaq: BOLT) Soars on Acquisition News
Investorideas.com ·
Bolt Biotherapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $7.7M | $7.7M | $7.9M | $5.7M |
| Net income | -$33.4M | -$63.1M | -$69.2M | -$88.1M |
| Diluted EPS | $-17.85 | $-33.06 | $-1.83 | $-2.36 |
| Total assets (year end) | $56.7M | $99.6M | $159.8M | $227.8M |
| Cash and equivalents (year end) | $11.7M | $7.2M | $10.8M | $9.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Bolt Biotherapeutics, Inc.
- Ticker
- BOLT (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Redwood City, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1641281
- Former names
- Bolt Therapeutics, Inc.
Frequently asked questions
What exchange is Bolt Biotherapeutics, Inc. listed on?
Bolt Biotherapeutics, Inc. trades on the Nasdaq under the ticker symbol BOLT.
What industry is Bolt Biotherapeutics, Inc. in?
Bolt Biotherapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Bolt Biotherapeutics, Inc. headquartered?
Bolt Biotherapeutics, Inc.'s business address on file with the SEC is in Redwood City, CA.
When does Bolt Biotherapeutics, Inc.'s fiscal year end?
Bolt Biotherapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Bolt Biotherapeutics, Inc. report?
Bolt Biotherapeutics, Inc. reported $7.7M in revenue for calendar year 2025, according to its SEC filings.